We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:ALLO
​
​
logo

Allogene Therapeutics (ALLO)

Nasdaq • ALLO • US0197701065

1.06Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 23, 2026, ORTEX estimated 19.1% of free float sold short, 9.2 days to cover, cost to borrow 0.54%. Sign up for live short interest data.

Market Cap

367m USD | # 6494 in US

Volume

6.76m shares | 11.05m USD

Shares Outstanding

346.47m

Free Float Shares

81.63% | 282.83m

News

ALLO key data

Allogene Therapeutics (Nasdaq: ALLO) has a market capitalization of $367.26M. Last close $1.06 (as of 2026-11-10); 52-week range $0.98 to $4.46. ORTEX data as of 2026-10-23: short interest was 19.13% of free float, 9.2 days to cover and the average cost to borrow was 0.54%. Sign up for live short interest data.

  • ALLO news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.